• Add to Favorites
  • Subscribe
  • Friend us on Facebook
  • Follow Caijing on Twitter

Finance »

Analysts estimate that the People's Bank of China(PBoC) is likely to avert another severe money shortage by more reverse repo operations.

A looming trust product default of 3 billion RMB (approximately US$500 million) recently raised concerns about the regulatory system of China’s financial industry.

The statement ends a crisis that may have evolved into the first ever mega default of a shadow bank product in the country.

New property loans rose 998.7 billion from a year ago to 2.34 trillion yuan, accounting for 28.1 percent of total new loans.

ICBC chairman Jiang Jianqing said investors should take a lesson from the case and get an understanding of the "moral hazards" in financial markets.

The one-year deposit rate at most will be 3.75 percent under the current rules, which is considerable lower than the expected returns offered by Internet finance products.

The People's Bank of China is offering the financial markets CNY120billion via the 21-day reverse repurchase agreements on Thursday.

Total foreign direct investment (FDI) in China rose by 5.25 percent in 2013 after the decline which was witnessed in 2012.

Bitcoin’s attractiveness has also not been lost on the world’s criminal element who have used it as an untraceable method to buy and sell drugs and other illegal goods.

The first panda bonds will be issued on the interbank bond market before long, underwritten by the Bank of China.

The move came following a three-week hiatus after the PBoC suspended open-market operations since December, 24th, 2013.

Hong Kong-listed mainland companies' shares held by domestic investors, especially the State-owned ones, currently cannot be traded in the H-share market.

The Shanghai Composite Index closed below the 2,000-point mark for the first time in five and a half months on Monday.

The commission made the statement amid industry concern that the process of IPO reform would be affected by the delay in the offering of Chinese drug maker Jiangsu Aosaikang Pharmaceutical Co Ltd.

Repayment of the 3-billion yuan ($496 million) product sold through the Industrial and Commercial Bank of China, the world's largest lender by assets, will probably be simply delayed.

  • First 
  • Previous 
  • Next 
  • Last 
  • Go
  • Editors’ Picks »